Please login to the form below

Not currently logged in
Email:
Password:

Puma

This page shows the latest Puma news and features for those working in and with pharma, biotech and healthcare.

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Paediatric use drugs. During its four-day meeting, the CHMP approved two new paediatric-use marketing authorisations (PUMAs) for off-patent drugs specifically developed for use in children. ... Kigabeq (vigabatrin), the other PUMA medicine, has been

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest appointments

  • New hires at Amgen, Eli Lilly and Zosano New hires at Amgen, Eli Lilly and Zosano

    Prior to joining Zosano, Lo served as the chief commercial officer for Puma Biotechnoly, and previously worked as senior vice president and chief commercial officer at Corcept Therapeutics.

  • Constellation Pharmaceuticals strengthens management team Constellation Pharmaceuticals strengthens management team

    Senderowicz has over 20 years’ experience in the life sciences sector, with his most recent role seeing him sit on Puma Biotechnology’s board of directors. ... Prior to his time at Puma, Senderowicz held several roles for the life sciences sector

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics